Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sonali Smith, MD
University of Chicago
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
56 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tunnell Cancer Center at Beebe Medical Center
Lewes, Delaware, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- St. Joseph Medical Center
Bloomington, Illinois, United States
- Graham Hospital
Canton, Illinois, United States
- Memorial Hospital
Carthage, Illinois, United States
- University of Chicago Cancer Research Center
Chicago, Illinois, United States
- Eureka Community Hospital
Eureka, Illinois, United States
- Galesburg Clinic, Pc
Galesburg, Illinois, United States
- Galesburg Cottage Hospital
Galesburg, Illinois, United States
- Mason District Hospital
Havana, Illinois, United States
- Hopedale Medical Complex
Hopedale, Illinois, United States
- Mcdonough District Hospital
Macomb, Illinois, United States
- Bromenn Regional Medical Center
Normal, Illinois, United States
- Community Cancer Center
Normal, Illinois, United States
- Community Hospital of Ottawa
Ottawa, Illinois, United States
- Oncology Hematology Associates of Central Illinois, Pc - Ottawa
Ottawa, Illinois, United States
- Cancer Treatment Center at Pekin Hospital
Pekin, Illinois, United States
- Ccop - Illinois Oncology Research Association
Peoria, Illinois, United States
- Methodist Medical Center of Illinois
Peoria, Illinois, United States
- Osf St. Francis Medical Center
Peoria, Illinois, United States
- Oncology Hematology Associates of Central Illinois, Pc - Peoria
Peoria, Illinois, United States
- Proctor Hospital
Peoria, Illinois, United States
- Illinois Valley Community Hospital
Peru, Illinois, United States
- Perry Memorial Hospital
Princeton, Illinois, United States
- St. Margaret'S Hospital
Spring Valley, Illinois, United States
- Elkhart General Hospital
Elkhart, Indiana, United States
- Howard Community Hospital
Kokomo, Indiana, United States
- Center for Cancer Therapy at Laporte Hospital and Health Services
La Porte, Indiana, United States
- Ccop - Northern Indiana Cr Consortium
South Bend, Indiana, United States
- Memorial Hospital of South Bend
South Bend, Indiana, United States
- Saint Joseph Regional Medical Center
South Bend, Indiana, United States
- South Bend Clinic
South Bend, Indiana, United States
- Cancercare of Maine at Eastern Maine Medical Center
Bangor, Maine, United States
- Union Hospital Cancer Program at Union Hospital
Elkton MD, Maryland, United States
- Lakeland Regional Cancer Care Center - St. Joseph
Saint Joseph, Michigan, United States
- Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
St Louis, Missouri, United States
- Cancer Resource Center - Lincoln
Lincoln, Nebraska, United States
- Alegant Health Cancer Center at Bergan Mercy Medical Center
Omaha, Nebraska, United States
- Ccop - Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2008
- Primary completion
- 30 Sept 2011
- Completion
- 28 Feb 2015
- Last update posted
- 6 Jul 2016
- Registered enrollment
- 30
- Registry id
- NCT00516217
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.